Promising results for weight-loss treatments that could compete with Ozempic and Wegovy, along with new screening recommendations for fatty-liver disease,...
Wall Street’s obsession with next-generation obesity and diabetes treatments intensified over the weekend as drugmakers presented new clinical-trial data on the drugs — including weight-loss pills in development that could become alternatives to popular injectables like Wegovy and Ozempic.
Eli Lilly’s LLY orforglipron, another once-daily pill, achieved up to 14.7% average weight loss at 36 weeks in adults with obesity or overweight, according to data shared at the ADA conference. More than half of Americans are concerned about their weight, and 50% are interested in taking weight-loss drugs, according to a recent survey by health news organization Stat and the Harris Poll, a market-research and consulting firm. Nearly half of the U.S. adults surveyed said they would spend up to $100 a month on such medications.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New pill forms of Ozempic, Wegovy a diabetes and weight-loss ‘game-changer’If approved, the new pill forms of semaglutide could revolutionize the fast-changing weight-loss landscape.
Read more »
A new pill may work as well as Ozempic and Wegovy shots to treat obesityNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes
Read more »
A daily pill may work as well as Ozempic, Wegovy shots to treat obesity: studyNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs may work as well as injections — even in hard-to-treat people with diabetes.
Read more »
Ozempic-Wegovy pill may be on the way: Trial shows promising results for new weight loss tabletA tablet form of semaglutide for weight loss showed positive results in phase 3 clinical trials, researchers announced at the American Diabetes Association (ADA) Scientific Session in Los Angeles, California.
Read more »
High-dose pill with the medication in the popular weight-loss injection Wegovy may be nearDrugmaker Novo Nordisk plans to ask the FDA to OK the weight-loss tablets later this year. Two new studies show significant success with them.
Read more »
‘RHOC’ star Emily Simpson claps back at rumors she took Ozempic to lose weightThe “Housewife” responded to a troll who said it is “sad” how she believes she “needs to change her body temporarily.”
Read more »